Movement is Life banner

Innovative European Technology Now In A City Near You

Countries of Operation
1 +
Successful Treatments
1000 +
Happy Pateints
1 %

Fed up with multiple sessions of surgical treatment for your debilitating joint pain?

AMT®-RA is an innovative, patented technology that eliminates joint pain & restores functions.

Section 5 - Homepage

Treatable Indications

AMT®-RA is recommended by physicians in several Joint & Muscular conditions

Post Arthroscopy
Joint Stiffness

Reason We Do What We Do


Have questions? We have the answers!

No, AMT®-RA is an innovative technology which does not involve platelets or any other blood component. AMT®-RA uses healthy tissue grafts from your own body. PRP therapy requires series of sessions, but AMT®-RA is designed to provide results in just a single session.

No, AMT®-RA, does not requires harvesting of body fat. There is no surgical procedure required to perform this treatment. The healthy tissue grafts are obtained with a simple biopsy procedure performed by the physician. It is a painless procedure performed in a sterile setup.


AMT®-RA is a procedure performed in an ambulatory setup and is complete under an hour. You don’t need to get admitted in a hospital for pre or post care.

After the procedure, you are advised to take rest for 48 hrs, followed by light movement of the treated joints. Within a week of the treatment, you are encouraged to perform your daily activities as normal as possible. You will see a gradual reduction in pain & increased a mobility within 4-6 weeks. Based on your condition, the physician will either recommend the course of action. 

The cost depends on 2 main factors: how severe your condition is and how many joints or areas of the body you are looking to have treated. Trained AMT®-RA Physicians will be able to answer this question for you more thoroughly after your initial examination and review of diagnostic findings.

Unfortunately, insurance companies do not cover such treatmensts, so the treatments are self-pay. Your physician will be able to provide solutions regarding the treatment cost. We encourage to speak with the physician.

About Autologous Micrografting By Regenera Activa

Autologous Micrografting Technology by Regenera Activa (AMT®-RA) is a regenerative technology developed by Regenera Activa Worldwide a global biotechnological company. Since our foundation in 2014, more than 250,000 patients worldwide have benefited from our technology. This technology is the result of more than ten years of biotechnological research, which today is shedding new light on the field of regenerative medicine. The Regenera Activa brand covers a line of high-performance class IIa medical devices aimed at a wide range of therapeutic areas.

Our headquarters are located in Barcelona, Spain, with distributors in more than 60 countries. To fulfill our vision of becoming the reference and leader company in Regenerative Science worldwide, we are expanding to new markets while investing in R&D projects to bring patients the most innovative and up-to-date technology to cover their unmet medical needs.

IMPORTANT SAFETY INFORMATION                                                                                                                        EXPAND +

Exciting Partnership As RegeneraActiva Teams Up with Romanian Rugby Union

Exciting Partnership As RegeneraActiva Teams Up with Romanian Rugby Union


Important Information

The content of this Website is intended for informational purposes only and should not be used as a substitute for advice provided by a qualified healthcare professional. The Website serves as a resource platform for clinicians to assist clinics in integrating AMT®-RA into their practice.

AMT®-RA is a procedural protocol developed by orthopedic surgeons, traumatologists & sports medicine specialists for sports rehabilitation & traumatology. This protocol uses a micrografting device Rigenera® Manufactured by HBW a medical device manufacturing company committed to designing and manufacturing medical products of the highest quality. HBW has received ISO13485:2016 certification for the quality management system. This medical device is a regulated healthcare product, which under European regulations bears the CE mark.

Safety Information

AMT®-RA procedure is not for everyone. You should not have the AMT®-RA treatment in areas with metal, electrical, or electronic implants/devices.

Tell your doctor if you have any medical conditions as AMT®-RA should not be used in patients with fever, malignant tumor, hemorrhagic conditions, epilepsy, recent surgical procedure, pulmonary insufficiency, pregnancy, arthritis rheumatoid (positive rheumatoid factor), family-related inflammatory arthritis, hematoma auris (or “cauliflower ear”), other inflammatory general diseases which are not controlled., any autoimmune disease not controlled, ear reconstruction or otoplasty, knee infection or active synovitis, present articular fibrosis, meniscopathy.

AMT®-RA should not be used in patients with Graves’ disease (an autoimmune disorder that causes overactive thyroid), active bleeding disorders, or seizure disorders.

Common side effects may include, but may not be limited to, muscular pain, temporary muscle spasms, temporary joint or tendon pain, and redness at or near the treatment site.

Ask your Healthcare Provider if AMT®-RA is right for you.

Patient Results May Vary.

This site is for visitors from Europe, the Middle East, Asia, and Africa. The third-party trademarks used herein are trademarks of their respective owners.

©2023 Regenera Activa Worldwide, All rights reserved.

Become a certified AMT®-RA Physician.


error: Content is protected !!